1. AB0449 PAIN REDUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TOFACITINIB MONOTHERAPY WITH OR WITHOUT PAIN MEDICATION: A POST HOC ANALYSIS OF POOLED DATA FROM PHASE 2, PHASE 3 AND PHASE 3B/4 STUDIES. (June 2019) Authors: Taylor, Peter C.; Laar, Mart van de; Curtis, Jeffrey R.; Azevedo, Valderilio F.; Rivas, Jose Luis; Dahl, Palle; Wang, Lisy; Iikuni, Noriko; Shi, Harry; Woolcott, John; Benkhalifa, Salim; Gomez-Reino, Juan Jose; Dougados, Maxime Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 1687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus—the Hopkins Lupus Cohort. Issue 1 (11th March 2015) Authors: Al Sawah, Sarah; Zhang, Xiang; Zhu, Baojin; Magder, Laurence S; Foster, Shonda A; Iikuni, Noriko; Petri, Michelle Journal: Lupus science & medicine Issue: Volume 2:Issue 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. LB0004 METHOTREXATE WITHDRAWAL IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO ACHIEVE LOW DISEASE ACTIVITY WITH TOFACITINIB MODIFIED-RELEASE 11 MG ONCE DAILY + METHOTREXATE: A RANDOMISED NON-INFERIORITY PHASE 3B/4 STUDY. (June 2019) Authors: B. Cohen, Stanley; Pope, Janet; Haraoui, Boulos; Irazoque-Palazuelos, Fedra; Korkosz, Mariusz; Diehl, Annette; Luis Rivas, Jose; Lukic, Tatjana; Liu, Shixue; Stockert, Lori; Iikuni, Noriko; Keystone, Edward Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Live Zoster Vaccine in Patients With Rheumatoid Arthritis Treated With Tofacitinib With or Without Methotrexate, or Adalimumab With Methotrexate: A Post Hoc Analysis of Data From a Phase IIIb/IV Randomized Study. Issue 3 (27th February 2020) Authors: Calabrese, Leonard H.; Abud‐Mendoza, Carlos; Lindsey, Stephen M.; Lee, Sang‐Heon; Tatulych, Svitlana; Takiya, Liza; Iikuni, Noriko; Soma, Koshika; Luo, Zhen; Fleischmann, Roy Journal: Arthritis care & research Issue: Volume 72:Issue 3(2020) Page Start: 353 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Methotrexate withdrawal in patients with rheumatoid arthritis who achieve low disease activity with tofacitinib modified-release 11 mg once daily plus methotrexate (ORAL Shift): a randomised, phase 3b/4, non-inferiority trial. (September 2019) Authors: Cohen, Stanley B; Pope, Janet; Haraoui, Boulos; Irazoque-Palazuelos, Fedra; Korkosz, Mariusz; Diehl, Annette; Rivas, Jose L; Lukic, Tatjana; Liu, Shixue; Stockert, Lori; Iikuni, Noriko; Keystone, Edward C Journal: Lancet Issue: Volume 1:Number 1(2019) Page Start: e23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. MHC2TA is associated with rheumatoid arthritis in Japanese patients. Issue 2 (7th November 2006) Authors: Iikuni, Noriko; Ikari, Katsunori; Momohara, Shigeki; Tomatsu, Taisuke; Hara, Masako; Yamanaka, Hisashi; Okamoto, Hiroshi; Kamatani, Naoyuki Journal: Annals of the rheumatic diseases Issue: Volume 66:Issue 2(2007) Page Start: 274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial. Issue 2 (1st October 2019) Authors: Strand, Vibeke; Mysler, Eduardo; Moots, Robert J; Wallenstein, Gene V; DeMasi, Ryan; Gruben, David; Soma, Koshika; Iikuni, Noriko; Smolen, Josef S; Fleischmann, Roy Journal: RMD open Issue: Volume 5:Issue 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. THU0193 EFFICACY OF TOFACITINIB MONOTHERAPY, TOFACITINIB WITH METHOTREXATE AND ADALIMUMAB WITH METHOTREXATE IN PATIENTS WITH EARLY (≤2 YEARS) VS ESTABLISHED (>2 YEARS) RHEUMATOID ARTHRITIS: A POST HOC ANALYSIS OF DATA FROM ORAL STRATEGY. (June 2019) Authors: Takeuchi, Tsutomu; Tanaka, Yoshiya; Sugiyama, Naonobu; Iikuni, Noriko; Soma, Koshika; Shi, Harry; Mysler, Eduardo; Moots, Robert J; Smolen, Josef S.; Fleischmann, Roy Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Use of multibiomarker disease activity scores in biosimilarity studies for the treatment of patients with rheumatoid arthritis. Issue 2 (30th September 2022) Authors: Kay, Jonathan; Bock, Amy E; Rehman, Muhammad; Zhang, Wuyan; Zhang, Min; Iikuni, Noriko; Alvarez, Daniel F Journal: RMD open Issue: Volume 8:Issue 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗